Cure My Disease

Don't miss your cure!

 Log in / Sign up

Placental protein clues may unlock mystery of poor fetal growth

NCT ID NCT07701837

Recruiting now Knowledge-focused Sponsor: Samsun University Source: ClinicalTrials.gov ↗

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study examines whether placentas from pregnancies with intrauterine growth restriction (IUGR) have different levels of certain progesterone receptors compared to healthy pregnancies. Researchers will analyze placental tissue collected after delivery from 90 women. The goal is to better understand the biological causes of IUGR, which affects fetal growth.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If this study finds clear differences in receptor levels, it could point toward new ways to detect or manage intrauterine growth restriction.
What could go wrong
This is a small observational study, not a treatment trial. It can show associations but cannot prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FETAL GROWTH RESTRICTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fetal growth restriction placenta disorder placental insufficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FETAL GROWTH RESTRICTION PGRMC1 PGRMC2 PLACENTA PLACENTAL DYSFUNCTION PREGNANCY PROGESTERONE MEMBRANE RECEPTOR

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Samsun University Faculty of Medicine Samsun Training and Research Hospital

    RECRUITING

    Samsun, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.